[Central nervous system infection mimicking neuropsychiatric systemic lupus erythematosus: A case report]. [PDF]
Beijing Da Xue Xue Bao Yi Xue BanZhao K, Lu F, Wang Y.
europepmc +1 more source
[Molecular imprinting strategies and advances targeting biomembranes]. [PDF]
Se PuYuan XT, Wang L, Chen LX, Hu LH.
europepmc +1 more source
Linchuang shenzangbing zazhi, 2013 目的 探讨苦参素治疗维持性血液透析患者合并慢性丙型肝炎的效果、不良反应。方法收集维持性血液透析合并慢性丙型肝炎患者26例,随机分为治疗组和对照组,每组13例。治疗组给予聚乙二醇干扰素α-2a 180μg,肌肉注射,每周1次,疗程6个月,联合苦参素葡萄糖注射液100 ml静滴3个月。对照组仅给予聚二醇干扰素α-2a 180μg,肌肉注射,每周1次,疗程6个月。观察治疗后12周、24周及停药后随访24周血清丙型肝炎病毒-RNA滴度中位数水平及丙型肝炎病毒-RNA阴转率,同时观察治疗前、后不良反应。结果 ...
doaj
[How I manage relapsed/refractory B-cell acute lymphoblastic leukemia patients treated with CD19 CAR- T cells throughout whole-process management]. [PDF]
Zhonghua Xue Ye Xue Za ZhiWang Y.
europepmc +1 more source
[Research progress of molecular imprinting technology in the field of disease diagnosis and therapy]. [PDF]
Se PuZhu R, Cai GP, Zheng HJ, Jia Q.
europepmc +1 more source
[Research progress on paper-based microfluidic chips in pathogen detection]. [PDF]
Se PuLiu XT, Shi J, Shi M.
europepmc +1 more source
Linchuang shenzangbing zazhi, 2013 目的 观察恩替卡韦联合糖皮质激素治疗乙型肝炎(乙肝)病毒相关性肾炎的临床效果。方法 选取在我完住院的乙肝病毒相关性肾炎患者65例,将患者随机分成2组。单一抗病毒组30例,单用恩替卡韦抗病毒治疗。联合治疗组35例,恩替卡韦抗病毒联合适量、短期糖皮质激素治疗。2组均给予常规护肝、降酶及保护肾功能治疗。对所有患者治疗前、后乙肝病毒DNA、肝功能、肾功能、血尿常规进行测定。结果 在抗病毒、护肝方面,治疗12个月后,2组血清乙肝病毒DNA载量及丙氨酸氨基转移酶、天冬氨酸氨基转移酶水平下降幅度均无明显差异 ...
doaj
[Treatment and Prospects of Focal Segmental Glomerulosclerosis]. [PDF]
Sichuan Da Xue Xue Bao Yi Xue BanDeng T +6 more
europepmc +1 more source
[Phase Ⅲ, multicenter, randomized, double-blinded, positive-controlled trial on the efficacy and safety of maribavir compared with valganciclovir in the treatment of post-transplant cytomegalovirus infection: Subgroup analysis of AURORA Trial in the Chinese population]. [PDF]
Zhonghua Xue Ye Xue Za ZhiXuan L +9 more
europepmc +1 more source